Amneal Pharmaceuticals Executive and Leadership Team

Chirag Patel, the President & Co-Chief Executive Officer at Amneal Pharmaceuticals, directs the company's overarching strategy and operational execution. Patel guides Amneal's evolution into a dynamic, purpose-driven pharmaceutical entity, focusing on expanding access to essential medicines globally. This leadership involves integrating the company's robust U.S. generics business with its growing branded portfolio, institutional injectables, and biosimilars. Patel's strategic vision propels Amneal's mission to deliver innovation, complex products, and broadened portfolios across new categories and geographies. Overseeing significant investments in scientific rigor, production capabilities, and commercial infrastructure, Patel ensures Amneal remains at the forefront of pharmaceutical development. The President & Co-Chief Executive Officer also champions substantial investment in people, fostering leadership development and employee well-being to accelerate the company's ability to meet critical medical needs and provide solutions for future health challenges. Chirag Patel's leadership ensures Amneal consistently delivers outcomes that make quality medicines more accessible and affordable.

Hiral Kuvadia, the Chief of Staff To President at Amneal Pharmaceuticals, provides critical support and strategic alignment for the President & Co-Chief Executive Officer's initiatives. Kuvadia facilitates the execution of key corporate strategies, ensuring seamless communication and coordination across various departments and leadership levels. This role involves managing high-priority projects, optimizing operational workflows, and driving efficiency in day-to-day business activities. The Chief of Staff To President acts as a key liaison, translating strategic objectives into actionable plans and monitoring progress against critical milestones. Kuvadia's responsibilities extend to enhancing organizational effectiveness and supporting the President & Co-Chief Executive Officer in navigating complex business challenges. By streamlining operations and fostering cross-functional collaboration, Hiral Kuvadia directly contributes to Amneal Pharmaceuticals' mission of delivering more affordable access to essential medicines and making healthy possible.

Sanjay Jain, the President, Amneal (India) at Amneal Pharmaceuticals, spearheads the company's strategic initiatives and operational management within the Indian market. Jain directs the expansion of Amneal's presence, focusing on delivering affordable access to essential medicines and complex products tailored to regional needs. This leadership role involves cultivating strong local partnerships, optimizing manufacturing and distribution networks, and ensuring compliance with Indian regulatory standards. The President, Amneal (India) plays a crucial part in integrating global capabilities with local market dynamics, driving growth for Amneal's generics, branded, and biosimilar offerings. Sanjay Jain's efforts are pivotal in strengthening Amneal's global footprint and reinforcing the company's commitment to making quality medicines more accessible and affordable in one of the world's largest pharmaceutical markets. Jain's leadership directly supports the overarching mission to make healthy possible.

Jatin Savani, the Sr. General Manager - Global Quality Management (Compliance, Supplier Quality, External Manufacturing and Chief Marketing Officer, SETE) at Amneal Pharmaceuticals, orchestrates comprehensive quality assurance and marketing strategies across global operations. Savani directs all facets of compliance, supplier quality, and external manufacturing, ensuring adherence to the highest industry standards and regulatory requirements. This critical role involves safeguarding product integrity and operational excellence throughout the supply chain. Concurrently, as Chief Marketing Officer for SETE, Savani drives market penetration and brand strategy for specific product segments, aligning commercial efforts with quality imperatives. The Sr. General Manager - Global Quality Management (Compliance, Supplier Quality, External Manufacturing and Chief Marketing Officer, SETE) ensures that Amneal's commitment to delivering high-quality, affordable medicines is upheld across all production and market-facing activities. Jatin Savani's dual focus on stringent quality management and effective marketing propels Amneal's mission to make healthy possible.

Vikram Nair, the Senior Vice President, Chief Information Officer at Amneal Pharmaceuticals, architects and executes the company's global technology strategy. Nair oversees all aspects of information technology, driving digital transformation and ensuring robust, scalable infrastructure to support Amneal's expanding business operations. This leadership role involves implementing advanced technological solutions that enhance scientific rigor, production capabilities, and commercial reach. The Senior Vice President, Chief Information Officer ensures seamless integration of IT systems across Amneal's U.S. generics, branded business, institutional injectables, and biosimilars portfolios. Nair's focus on cybersecurity and data integrity protects sensitive information and supports regulatory compliance. By leveraging technology, Vikram Nair empowers Amneal Pharmaceuticals to deliver innovation, improve operational efficiency, and accelerate the company's ability to provide more affordable access to essential medicines, directly contributing to the mission of making healthy possible.